Goldman Sachs made a number of changes in the Specialty Pharmaceuticals sector.

The firm upgraded Allergan Inc. (NYSE: AGN) from Neutral ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE